Manufacturing / Pharmaceutical Preparations
Erasca, Inc.
ERAS
$18.07
+$0.46 (+2.62%)
Price as of Aug 25, 2026 16:11 UTC
6.2 B
Market Cap (Mid Cap)
7%
IV Rank
103.3%
Implied Volatility
Nov 10
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.79
Bullish skew
Implied Volatility
103.3%
0% percentile
IV vs Realized
Options rich
30d HV 59.9%
Options Heat Map
Delta-risk grid for ERAS options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
3 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Fuchs Charles S. | Grant | 1,300,000 | $0 | |
| Apr 01, 2026 | Garner Ebun | Exercise | 80,000 | $136,000 | |
| Apr 01, 2026 | Garner Ebun | Sell | 80,000 | $1,312,000 | |
| Apr 01, 2026 | Garner Ebun | Exercise | 80,000 | $0 | |
| Mar 04, 2026 | Morris Shannon | Exercise | 20,000 | $34,000 | |
| Mar 04, 2026 | Morris Shannon | Sell | 20,000 | $300,760 | |
| Jan 29, 2026 | Lim Jonathan E | Grant | 2,000,000 | $0 | |
| Jan 29, 2026 | Garner Ebun | Grant | 560,000 | $0 | |
| Jan 29, 2026 | Varney Michael David | Grant | 96,000 | $0 | |
| Jan 29, 2026 | Morris Shannon | Grant | 625,000 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$0.12 | |||
| Aug 06, 2026 | Q2 2026 | -$0.12 |
Track ERAS with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ERAS and your entire portfolio.